Wall Street analyst estimates for Shuttle Pharmaceuticals Holdings, Inc. (SHPH): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-09-15 | |||
| 2026-05-15 | $-4.30 | ||
| 2026-04-01 | $-12.90 | ||
| 2025-11-13 | $-1.05 | ||
| 2025-08-12 | $-3.29 | ||
| 2025-05-08 | $-7.50 | ||
| 2025-03-20 | $-0.80 | ||
| 2024-11-13 | $-39.75 |
Valuation Ratios
| Price / Book | 0.47 |
| EV / EBITDA | -0.12 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | $18739 | $18000 | $54951 | $60834 | $5972 | 0 | 0 | 0 |
| Gross Profit | -$18739 | -$18000 | -$54951 | -$60834 | -$5972 | 0 | 0 | 0 |
| Research & Development | -$836 | $55572 | $161772 | $1.0M | $1.0M | $3.5M | $3.6M | $4.1M |
| Selling, General & Admin | $185987 | $513059 | $347750 | $721184 | $1.3M | $2.4M | $4.1M | $7.9M |
| Operating Expenses | $185151 | $568632 | $454571 | $1.7M | $2.3M | $5.9M | $7.7M | $11.9M |
| Operating Income | -$203890 | -$586630 | -$509522 | -$1.7M | -$2.3M | -$5.9M | -$7.7M | -$11.9M |
| EBITDA | -$183971 | -$577223 | -$711151 | -$1.0M | -$4.3M | -$4.0M | -$7.8M | -$11.4M |
| Interest Expense | $10881 | $30916 | $39630 | $50788 | $670610 | $2.6M | $1.4M | $70828 |
| Pre-tax Income | -$213594 | -$626139 | -$805732 | -$1.2M | -$5.0M | -$6.6M | -$9.1M | -$11.7M |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -$213594 | -$626139 | -$805732 | -$1.2M | -$5.0M | -$6.6M | -$9.1M | -$11.7M |
| EPS | $-0.16 | $-0.46 | $-0.68 | $-0.95 | $-3.00 | $-4.10 | $-8857.30 | $-71.60 |
| EPS (Diluted) | $-0.16 | $-0.46 | $-0.68 | $-0.95 | $-3.00 | $-4.10 | $-8857.30 | $-71.60 |
| Shares Outstanding (Diluted) | $1.4M | $1.4M | $1.4M | $1.4M | $1.0M | $1.6M | $1.0M | $163792 |
Price
| Price | $3.13 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | US |
Related companies: AKAN · BBLG · BIVI · HSCS · IMCC · ISPC · MSPR
Explore sector: Healthcare · Drug Manufacturers - Specialty & Generic
More sections of SHPH: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks